We then examined the correlation between CDX2 expression and clinical and pathological parameters, such as gender, size of the tumor, lymph node metastasis, histological grade, depth of tumor invasion and metastasis in the GCC patient samples (Table 2). The gene discussed is CDX2; the disease is neoplasm.